Kathmere Capital Management LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Kathmere Capital Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,258 shares of the healthcare conglomerate’s stock after selling 236 shares during the period. Kathmere Capital Management LLC’s holdings in UnitedHealth Group were worth $2,660,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. WINTON GROUP Ltd purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $228,000. One Capital Management LLC lifted its holdings in UnitedHealth Group by 67.9% in the second quarter. One Capital Management LLC now owns 4,611 shares of the healthcare conglomerate’s stock worth $2,348,000 after buying an additional 1,864 shares during the period. Renaissance Technologies LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $36,323,000. Luts & Greenleigh Group Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $408,000. Finally, Lmcg Investments LLC grew its stake in UnitedHealth Group by 1.9% in the second quarter. Lmcg Investments LLC now owns 32,323 shares of the healthcare conglomerate’s stock worth $16,461,000 after purchasing an additional 599 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on UNH. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $543.76 on Wednesday. The firm has a fifty day simple moving average of $554.45 and a two-hundred day simple moving average of $563.12. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $500.41 billion, a P/E ratio of 35.42, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company earned $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.